Tag: Covid

Categories
Health

Covid Surge in Michigan Alarms Well being Specialists

Covid Surge in Michigan Alarms Health Experts

The country is a study of contrasts. New Jersey, New York, Connecticut, and other northeastern states continue to report high levels of cases, and Illinois, Minnesota, and several other Midwestern states have seen worrying upward movements. In large parts of the south and west, however, the number of cases remains relatively low.

California reports continued declines of about 2,600 cases per day, compared with more than 40,000 daily for much of January. Arizona has an average of 570 cases per day, compared with more than 10,000. And in Arkansas, fewer than 200 cases are announced on most days, a decrease of 40 percent in the past two weeks.

But if any place offers any glimpse into the threat of a new climb, it’s Michigan.

Health officials attributed the rapid increase in cases in part to variant B.1.1.7, which was originally identified in the UK and is widespread in Michigan. But they have also seen a wider return to pre-pandemic life, translating into relaxation of masking, social distancing, and other strategies to slow the spread of the virus – many weeks before a significant portion of the population is vaccinated. On Thursday, Michigan officials announced that they had identified their first case of the P.1 variant, which is widespread in Brazil and has now been found in more than 20 US states.

Nationwide, more than 2,300 coronavirus patients are being hospitalized, a number that has more than doubled since the beginning of March. Five hospitals in the Henry Ford system in the Detroit area had a total of 75 coronavirus patients in the week of March 8. As of Tuesday, the hospitals were up to 267 patients. On Monday, the health system announced that it would reintroduce a policy to limit visitor numbers at several hospitals in response to the recent surge.

Dr. Adnan Munkarah, clinical director of the Henry Ford health system, said more coronavirus patients are now surviving the disease than in 2020, also because they are younger.

But he’s frustrated, he said, and his staff is exhausted. “We were hoping that we would have better control of things now,” he said.

Categories
Health

Boston Purple Sox chairman hopes Covid sport cancellations a ‘uncommon occasion’

Boston Red Sox chairman hopes Covid game cancellations a 'rare event'

Tom Werner, chairman of Boston Red Sox, told CNBC Thursday that he did not expect any coronavirus outbreaks that would materially change the course of the Major League Baseball season.

Werner’s comments on “Squawk Box” came on opening day, the start of the second MLB season to be played during the pandemic following last year’s shortened campaign.

“I’m sure we have gone beyond what we were six months ago. The baseball protocols are very strong. The players heed them,” Werner said. “Sure, I think there might be an outbreak on occasion, but I think it will be a rare occurrence when some games are canceled.”

After Werner’s appearance on CNBC, the competition between the Washington Nationals and the New York Mets, which was scheduled for Thursday evening, was postponed due to Covid concerns. A Nationals player tested positive for the coronavirus earlier this week and some teammates are being quarantined after contact tracing.

Some coronavirus protocols could relax for teams this season once a certain vaccination threshold is reached. While not many MLB players have been vaccinated yet, the league expects that number will rise once the teams are back in their hometowns after spring training, according to The Associated Press.

The 2020 season was delayed by months after the pandemic hit the US, but a 60-game schedule finally began in July. Dozens of games were postponed during the season due to Covid cases, despite making the playoffs as planned, and the Los Angeles Dodgers won the World Series in late October.

Boston Red Sox members watch during a team training session prior to the 2021 opening game on March 31, 2021 at Fenway Park in Boston, Massachusetts.

Billie Weiss | Boston Red Sox | Getty Images

This year the schedule for 162 games is back – as are the fans in the stadiums. Last year regular season games were played in empty stadiums. A limited number of spectators were allowed to take part in some playoff competitions in the fall.

At the start of the season, capacity at the Red Sox’s historic home, Fenway Park, is limited to 12%, which is just over 4,500 fans, according to NBC Boston.

Werner hopes that the number will only increase in the coming months when more Americans are vaccinated against Covid.

“I certainly don’t have a crystal ball, but we hope the vaccine rollout continues to proceed swiftly and I would certainly hope that the stadiums will be at full capacity by the end of the season,” he said.

About 29% of the US population had received at least one dose of Covid vaccine by Wednesday, according to the Centers for Disease Control and Prevention. This includes around 16% of the country’s population who are fully vaccinated.

The Pfizer and Moderna vaccines require two doses for complete protection of immunity, while the Johnson & Johnson vaccine is a single shot. These are the only three emergency vaccinations approved in the United States

Categories
Health

U.S. begins testing Moderna’s Covid vaccine booster photographs for variant from South Africa

U.S. begins testing Moderna's Covid vaccine booster shots for variant from South Africa

A nurse draws a vaccine for Moderna Coronavirus Disease (COVID-19) on March 5, 2021 at the East Valley Community Health Center in La Puente, California.

Lucy Nicholson | Reuters

The National Institutes of Health have started testing a new coronavirus vaccine from Moderna, which is designed to protect against a problematic variant first found in South Africa, the agency said on Wednesday.

According to the agency, the phase 1 study, which is led and funded by the National Institute for Allergies and Infectious Diseases of the NIH, will test how safe and effective the new shot is against the variant known as B.1.351 in around 210 healthy adults .

The study, which has already had some of the first vaccinations, will include approximately 60 adults who participated in Moderna’s original Covid-19 vaccine studies last year, as well as approximately 150 people who have not yet received a Covid-19 vaccine at one Statement.

Returning participants, who were given two syringes of the original vaccine 28 days apart at different doses early last year, will split up.

Some of them get a single booster shot with the new vaccine at a higher dose while others get the new vaccine at a lower dose, the statement said. Remaining participants will be offered a booster shot with the original vaccine “as part of a separate clinical trial protocol”.

Researchers will take blood samples from participants throughout the study, which can be tested against other circulating strains of the virus to see if the vaccine elicits an immune response.

The study will recruit volunteers in the Atlanta, Cincinnati, Seattle and Nashville, Tennessee areas and should be fully enrolled by the end of April, the agency said.

Variant B.1.351, first discovered in South Africa at the end of last year, has given scientists more cause for concern compared to other variants. The variant appears to spread more easily than the original “wild-type” strains, and research shows that it may evade some of the safeguards created by therapeutics and vaccines.

So far, 312 Covid-19 cases with variant B.1.351 have been identified in the United States, according to the latest data from the Centers for Disease Control and Prevention.

“Preliminary data shows that the COVID-19 vaccines currently available in the US should provide adequate protection against SARS-CoV-2 variants,” said NIAID Director and Chief Medical Officer of the White House, Dr. Anthony Fauci, in a statement.

“However, out of caution, NIAID has continued its partnership with Moderna to evaluate this variant vaccine candidate should an updated vaccine be required,” said Fauci.

The US Food and Drug Administration has already announced that it will accelerate the approval process for the updated vaccines, which target the problematic variants, so that no lengthy clinical trials are required.

However, an independent safety monitoring committee will continue to monitor the trials to ensure the shots are safe, the NIH statement said.

Categories
World News

Some Johnson & Johnson Covid Vaccine Doses Delayed in U.S. by Manufacturing facility Combine-Up

Some Johnson & Johnson Covid Vaccine Doses Delayed in U.S. by Factory Mix-Up

Workers at a Baltimore plant that made two coronavirus vaccines accidentally merged the ingredients a few weeks ago, contaminating up to 15 million doses of Johnson & Johnson’s vaccine and forcing regulators to delay approving the plant’s production lines.

The facility is operated by Emergent BioSolutions, a manufacturing partner of Johnson & Johnson and AstraZeneca, the Anglo-Swedish company whose vaccine is not yet approved for use in the United States. Federal officials attributed the error to human error.

The mix-up has delayed future shipments of Johnson & Johnson cans in the U.S. while the Food and Drug Administration investigates what happened. Johnson & Johnson has strengthened its control over the work of Emergent BioSolutions to avoid additional quality defects.

The mistake is a major embarrassment for both Johnson & Johnson, whose single-dose vaccine is credited with accelerating the national vaccination program, and Emergent, its subcontractor, who has received heavy criticism for its strong lobbying for federal contracts, particularly for the emergency Government Health Stock.

The bug does not affect any Johnson & Johnson cans currently shipped and used nationwide, including shipments that states are anticipating next week. All of these cans were made in the Netherlands, where the operations were fully approved by federal regulators.

More shipments of the Johnson & Johnson vaccine – expected to be 24 million doses next month – should come from the huge Baltimore facility. These supplies are now in question while quality control issues are being resolved according to those familiar with the matter.

Federal officials are still expecting enough doses from Johnson & Johnson and the other two approved coronavirus vaccine manufacturers to meet President Biden’s commitment to provide enough vaccines to immunize every adult by the end of May.

Pfizer is shipping its doses ahead of schedule, and Moderna is about to approve the supply of vaccine bottles of up to 15 doses instead of 10, further strengthening the country’s inventory.

The problems arose at a new facility the federal government hired last year to manufacture vaccines from Johnson & Johnson and AstraZeneca. The two vaccines use the same technology, which uses a harmless version of a virus – known as a vector – that is transferred into cells to make a protein, which then stimulates the immune system to produce antibodies. However, the Johnson and Johnson and AstraZeneca vectors are biologically different and not interchangeable.

At the end of February, one or more employees somehow mixed up the two during the production process and raised questions about training and supervision.

Vaccine manufacturing is a notoriously capricious science, and errors are often expected to occur and ruin batches. However, Emergent’s mistake went undetected for days until Johnson & Johnson quality controls discovered it, according to people familiar with the situation. By then, up to 15 million cans were contaminated, people said.

None of the cans ever left the plant and the lot has been quarantined.

Johnson & Johnson reported the mishap to federal regulators, who opened an investigation that delayed approval of the plant’s production lines. The company has increased the number of its own employees overseeing Emergent’s work and has introduced a number of new controls to protect against future errors.

Johnson & Johnson was already grappling with a manufacturing delay that caused the company to fail to meet its obligations to the federal government, but it appeared to be on track to catching up. 20 million doses had been administered by the end of March, and promises were made to deliver around 75 million additional doses by the end of May.

White House officials backed up their predictions in a phone call with governors on Tuesday. They forecast certain shipments from Pfizer and Moderna, but warned that Johnson & Johnson shipments would fluctuate.

In a statement late Wednesday, the company said it expected the steps it is now taking with Emergent would allow it to drop 24 million doses by the end of April, or whatever the federal government expects. However, this depends on Johnson & Johnson’s compliance with the Food and Drug Administration regulations.

Categories
Health

Convincing skittish mother and father to vaccinate their kids key to curbing Covid, says Dr. Hotez

Convincing skittish parents to vaccinate their children key to curbing Covid, says Dr. Hotez

To curb the spread of Covid-19 in the future, U.S. officials must convince skeptical parents to vaccinate their children, said Dr. Peter Hotez on Wednesday.

“There will have to be a lot of public communication and a lot of advocacy that needs to be done because parents will be a little skeptical about … a brand new mRNA technology for their children,” said Hotez, co-director of the Center for Vaccine Development Texas Children’s Hospital said CNBC’s “The News with Shepard Smith”.

Hotez’s comments came after Pfizer announced earlier in the day that its vaccine is 100% effective in children ages 12-15. Albert Bourla, CEO of Pfizer, said the company will soon submit the new data to the Food and Drug Administration and other regulators. He added Pfizer would request a change to its emergency permit to include anyone 12 and older.

“We see adolescents going to pediatric intensive care units, they get sick, especially those with underlying risk factors,” said Hotez. “If we really want to stop virus transmission, 80 to 85% of the population will have to be vaccinated now that we have variant B.1.1.7, which is so highly transmissible, and I think we could do that.” that by involving young people. “

Hotez said he thinks the US could “vaccinate maybe 75% of adults” by the summer but warned that “we are in the running with this B.1.1.7 variant,” leading to higher mortality and hospitalization rates .

Categories
Business

Covid worsened the gender hole, it can take 135 years to shut

Covid worsened the gender gap, it will take 135 years to close

The World Economic Forum predicts it will now take 135.6 years to reach gender equality – as the pandemic moves the world back a generation and delays parity by about 36 years.

Saadia Zahidi, executive director of the World Economic Forum, told CNBC, “100 years to global gender equality wasn’t good enough – and now (it’s) 136 years worldwide.”

“The pandemic has had a massive impact and essentially reversed much of the progress made in the past,” she told CNBC’s Capital Connection on Wednesday.

If companies want the… creativity and innovation that will bring them out of the crisis, they need diversity and must see this as a business investment.

Saadia Zahidi

Managing Director, World Economic Forum

One reason the gender gap has widened is that the sectors heavily employed by Covid-19 are mostly affected by women.

“Whether it’s travel and tourism that is closed around the world, or the consumer and retail sectors that are affected in so many countries, these are great employers for women,” Zahidi said.

A mother and daughter watch as speakers speak to the crowd at a demonstration against mandatory Covid-19 vaccines in Sydney, Australia.

Don Arnold | Getty Images News | Getty Images

Another factor is that many women took on additional duties during the home lockdown when schools were closed.

“It then meant a kind of double layer for women,” she said.

The WEF said data from market research firm Ipsos suggest that this “double shift” between paid and unpaid work has contributed to increased stress, anxiety about job security and difficulties in maintaining work-life balance.

Role of Governments and Businesses

Zahidi said governments have a “crucial role” to play in closing the gender gap.

For example, she said the authorities could invest in infrastructure to care for children and the elderly, which would be helpful given that women in “traditional” homes have such responsibilities.

Employers can also help women experience higher relative job losses and lower recruitment rates in industries that are recovering, she added.

“If companies want the … creativity and innovation that can get them out of the crisis, they need diversity, so they have to see it as a business investment,” Zahidi said.

Categories
Health

WHO warns of an increase in Covid instances and deaths: ‘We’re all struggling’

WHO warns of a rise in Covid cases and deaths: ‘We’re all struggling’

World Health Organization (WHO) Director General Tedros Adhanom Ghebreyesus attends a press conference after the Emergency Committee for Pneumonia Due to Novel Coronavirus 2019-nCoV attended a press conference in Geneva, Switzerland on January 22nd. 2020.

Christopher Black | WHO | Handout via REUTERS

The World Health Organization warned of a steady spike in Covid-19 cases and deaths in recent weeks and urged people on Wednesday to adhere to mask mandates and social distancing rules as the world enters a critical phase of the pandemic.

“We are in our second year of the pandemic. There is a lot of frustration and fatigue out there wanting this pandemic to be over, but as the transmission increases, it is going in the wrong direction,” said Dr. Maria Van Kerkhove, the WHO Technical Director of Covid-19, said during a Q&A at the organization’s headquarters in Geneva. “It’s far from over. We’re not talking about a handful of cases here and there. We’re still in the acute phase of the pandemic.”

The number of cases rose 14% worldwide last week – the sixth straight weekly increase – and the death toll rose for the third straight week, she said. Globally, there have been more than 128 million Covid-19 cases and 2.8 million deaths since the virus emerged just over a year ago, according to John Hopkins University.

The countries with the largest transmission leaps are India, the USA, Brazil, Turkey, Poland, Italy, Ukraine, the Philippines, Germany and Iran.

French President Emmanuel Macron on Wednesday ordered the country’s third national lockdown and said schools would close for three weeks as the country tries to fend off a third wave of infections that threatens to overflow hospitals.

“We will lose control if we don’t move now,” he said in a televised address to the nation.

The virus is “stronger, it’s faster” as new varieties emerge that are easier to spread and more deadly than the original wild strain of the virus, said Dr. Mike Ryan, WHO Emergency Program Director. “We all have problems” and fed up with restrictive bans, he said.

“It’s a turning point in the pandemic because the moment we have to stay on course with all of this, the numbers are rising and governments are turning back to restrictive measures,” he said.

Categories
Health

Covid was third main reason for dying in U.S. in 2020, behind coronary heart illness and most cancers, CDC says

Covid was third leading cause of death in U.S. in 2020, behind heart disease and cancer, CDC says

The body of a deceased patient is considered a health care worker treating individuals infected with coronavirus disease (COVID-19) on December 30, 2020 at the United Memorial Medical Center in Houston, Texas, United States.

Callaghan O’Hare | Reuters

Coronavirus was the third leading cause of death in the United States in 2020, after heart disease and cancer, according to a new study by the U.S. Centers for Disease Control and Prevention.

More than 3.3 million deaths were reported in the US last year, up 16% from 2019. This is according to early data released Wednesday by the National Vital Statistics System, which provides annual mortality statistics based on death certificates investigates and reports.

The deadliest weeks of last year were at the start of the pandemic and then in the middle of the holiday flood in the weeks leading up to April 11, with 78,917 deaths, and December 26, when 80,656 people died, the CDC found.

According to the study published on Wednesday, Covid-19 was listed as the root cause of 345,323 deaths. More Americans died in the process than accidental injuries, strokes, chronic lower respiratory diseases, Alzheimer’s, diabetes, influenza and pneumonia, and kidney disease.

Only heart disease and cancer killed more people than Covid-19 in the US in 2020 – heart disease killed 690,882 people and cancer killed 598,932.

Covid-19 replaced suicide in the top 10 leading causes of death in the United States, the study found. Overall, the annual death rate rose nearly 16% year over year in 2020, the first time since 2017, according to the CDC.

The highest annual death rates were reported among men, people age 85 and over, and people who are not Hispanic Black and Native American and Alaskan native, according to the CDC.

However, if you just look at Covid-19, Hispanic and Native American and Alaskan Native Americans, as well as those aged 85 and over, were more likely to die of the disease compared to any other group. Men died more often from Covid-19 than women.

CDC director Dr. Rochelle Walensky said after the study was published the results should “act as a catalyst” for Americans to reduce the spread of the virus and get vaccinated when it is their turn to get vaccinated.

“I know this is not easy and so many of us are frustrated with the disruption this pandemic has had in our daily lives, but we can do this as a nation that works together,” Walensky said during a White House press conference Covid-19

The agency’s first results were released months ahead of schedule as “freshness has improved and there is an urgent need for updated quality data during the global COVID-19 pandemic,” the researchers wrote.

Typically, it takes researchers 11 months after the end of the calendar year to “investigate specific causes of death and process and review data”. The daily Covid deaths reported by the CDC, while current, may underestimate the actual number of deaths due to “incomplete or late reports”.

“Preliminary death estimates provide an early indication of shifts in mortality trends and can guide public health policies and actions aimed at reducing the number of deaths directly or indirectly linked to the COVID-19 pandemic “write the researchers.

Some have tried to sow doubts about the real number of Covid-19 deaths, claiming they may have been overstated. However, in a separate CDC study released Wednesday, the agency found that the death certificates accurately reflected the number of reported coronavirus deaths.

The agency checked death certificates listing Covid-19 and at least one other concurrent illness. The CDC found that Covid-19 was reported in 97% of deaths alongside another condition that the virus might have caused, such as pneumonia or respiratory failure, or that contributed significantly to its severity, such as diabetes or high blood pressure.

A small fraction of them – 2.5% of the certificates – documented conditions not currently associated with Covid-19, the CDC noted.

“These results support the accuracy of COVID-19 mortality monitoring in the US using official death certificates,” the researchers said.

Categories
Business

Germany suspends use of AstraZeneca’s Covid shot for the under-60s

Germany suspends use of AstraZeneca's Covid shot for the under-60s

Medical syringes and small figures of people can be seen in front of the AstraZeneca logo displayed on a screen. On Saturday March 26th 2021 in Dublin, Ireland.

NurPhoto | NurPhoto | Getty Images

Germany has stopped using the coronavirus vaccine developed by AstraZeneca and Oxford University in the under 60s due to renewed concerns over reports of blood clots.

The move comes after the country’s medicines agency found 31 cases of a rare type of blood clot in a small number of people immunized with the coronavirus vaccine made by the Anglo-Swedish drug maker. The suspension is likely to deal another blow to the vaccine’s reputation.

What happened?

Initially, some regions suspended the use of the shot on Tuesday due to concerns about a possible link to rare but serious forms of blood clots. However, it was announced on Tuesday that the entire country will no longer distribute the vaccine to anyone under the age of 60 after the country’s independent vaccine committee known as STIKO recommended it.

The committee said in a statement on Tuesday that “after several consultations, the majority of the STIKO, with the help of external experts, decided to only recommend the Covid-19 AstraZeneca vaccine to people aged 60 and over.”

This decision was based “on the currently available data on the occurrence of rare but very severe thromboembolic side effects. This side effect occurred 4 to 16 days after vaccination, mainly in people (under) 60 years of age,” it said.

Regarding the question of giving the second dose of vaccine to younger people who have already received a first dose of the AstraZeneca vaccine, the German vaccine committee announced that it would issue guidelines on the matter by the end of April.

Germany’s Paul Ehrlich Institute, a federal agency and medical regulator, told CNBC that there have been 31 cases of blood clots in the cerebral veins – a condition known as sinus vein thrombosis or cerebral venous sinus thrombosis – reported as part of a spontaneous admission.

Out of that number, thrombocytopenia (a condition characterized by abnormally low blood platelet levels) has also been reported in 19 cases. In nine of these cases, those affected died.

All but two of the 31 cases concerned women between the ages of 20 and 63, while the two men affected were 36 and 57 years old, according to the Paul Ehrlich Institute.

It added that it “continues to examine and evaluate all incoming case reports and actively participate in the relevant discussions at EMA, the European Medicines Agency, where case reports from all EU Member States are evaluated.

To put the numbers in context: By Monday, almost 2.7 million people in Germany had received a first dose of the AstraZeneca vaccine, 767 people had received a second dose, according to the German health department, the Robert Koch Institute.

Hit AstraZeneca

“Everything is based on a principle and that is trust,” said Merkel at a press conference, reported Reuters. “Trust arises from the knowledge that every suspicion is counted in every individual case.” The 66-year-old Chancellor added that she would also be ready to receive the AstraZeneca vaccine “when it is my turn,” reported Deutsche Welle.

Still, the German move is sure to cause AstraZeneca more pain and confuse the public and worry about the vaccine.

AstraZeneca has already suspended its shot in a handful of European countries before the EMA and World Health Organization reviewed the vaccine’s safety data and concluded that it was “safe and effective” and that the benefits outweigh the risks.

The EMA said at the time, however, that it could not rule out a connection between the shot and the blood clots, which at least occur regularly in the general population. Enough concerns have been raised for Canada to suspend use of the vaccine in those under 55 due to fears of a possible association with blood clots.

However, clinical and real world data has shown the vaccine to drastically reduce Covid cases, hospital stays and deaths. The vaccine is a key part of vaccination programs in the UK and other countries and is viewed as an inexpensive vaccine that is easy to transport and store.

Drugmaker defends himself

Many scientists and the UK government have defended the shot, claiming it had saved thousands of lives.

In a statement to CNBC, AstraZeneca said that international regulators had determined that the benefits of the sting significantly outweighed any possible risks.

It said it continues to analyze its database of tens of millions of records for the vaccine to understand “whether these very rare cases of thrombocytopenia-related blood clots are more common than would naturally be expected in a population of millions of people “.

“We will continue to work with the German authorities to answer any questions,” he added.

The drug company stressed that “tens of millions of people around the world have received our vaccine. The vast amounts of data from two large clinical datasets and real evidence demonstrate its effectiveness and reinforce the role the vaccine can play in this public health crisis.”

Germany had previously not given the vaccine to people aged 65 and over because there was insufficient data on its effectiveness in this age group. However, when more data emerged showing it was safe and effective, it reversed that policy.

Categories
Health

Extra Looking forward to Covid Vaccine however Skeptics Stay, U.S. Ballot Says

More Eager for Covid Vaccine but Skeptics Remain, U.S. Poll Says

As eligibility to get the Covid-19 vaccination rapidly expanded to all adults in many states over the next month, a new survey shows that the number of Americans, especially black adults, who want to be vaccinated continues to grow. However, it has also been found that skepticism about vaccines persists, especially among Republicans and white Evangelical Christians, an issue that the Biden government has identified as an obstacle to achieving herd immunity and returning to normal life.

According to the latest monthly survey by the Kaiser Family Foundation, around 61 percent of adults have either received their first dose or are excited about one, up from 47 percent in January.

The shift was most noticeable among black Americans, some of whom were hesitant before but also had access problems. Since February, 14 percent more black adults said they wanted or had already received the vaccine. Overall, black adults, who have also received violent advertising campaigns from celebrities, local black doctors, clergy and public health officials, now want the vaccine in numbers almost comparable to other leading populations: 55 percent compared with 61 percent for Latinos and 64 percent for whites.

The Biden government has made justice a focus of its pandemic response, adding mass vaccination centers in several underserved communities. In early March, a New York Times analysis of state-reported race and ethnicity information found that vaccination rates for blacks in the United States were half that for whites and the gap was even greater for Hispanic Americans.

Dr. Reed Tuckson, founder of the Black Coalition Against Covid, welcomed the rising adoption rates but noted that practical issues still stand in the way of inclusion.

“The data and our anecdotal feedback encourage and support the need for equitable distribution and easily accessible vaccination sites run by trustworthy organizations,” he said. “The system has to support these decisions by doing the right thing to do the simple thing.”

Overall, the survey showed that the so-called waiting group – people who have not yet made a decision – is shrinking accordingly, now at 17 percent compared to 31 percent in January. The seven-day average of vaccines administered hit 2.77 million on Tuesday, an increase from the pace of the previous week. This is based on data reported by the Centers for Disease Control and Prevention.

The survey was conducted March 15-22 among a random sample of 1,862 adults.

Despite the progress, one in five adults (20 percent) said they would either definitely refuse the shot or would only be vaccinated if necessary for their job or school. A number of employers and institutions are considering making such a requirement. Last week, Rutgers University became the first major academic institution to require students to receive the vaccine this fall (with exceptions for medical or religious reasons).

The people most likely to speak out against vaccination identify themselves as Republicans (29 percent) or white Evangelical Christians (28 percent). In contrast, only 10 percent of black adults said they definitely wouldn’t get it.

According to the Kaiser poll and other polls, Republicans have changed little in their views on vaccine acceptance in recent months, despite being more open last fall, ahead of the November presidential election. The party-political divide between the Covid-19 shots is wide. Only 46 percent of Republicans say they received or intended to receive at least one shot, compared to 79 percent of Democrats.

No group is monolithic in their reasons for rejecting or accepting the vaccines. Those who are skeptical say they generally distrust the government and are concerned about the speed of vaccine development. Much of the online misinformation clings to a fast-spreading myth – that tracker microchips are embedded in the recordings.

For rural residents, access to the vaccine is so problematic that they simply don’t see the logistics and travel time involved as worth it.

With so many reasons cited for avoiding the vaccine, it can be difficult to get messages across to improve vaccine confidence. However, the most recent Kaiser report identified a few approaches that appear to be successful in getting people to think about the shots.

At least two-thirds of the so-called wait-and-see group said they would be convinced by the message that the vaccines are “almost 100 percent effective in preventing hospital stays and the death of Covid-19”. Other strong messages included information that the new vaccines are based on 20 year old technology, that the vaccine trials have involved a wide variety of candidates, and that the vaccines are free.

The survey also found that many people who hesitate would be open to certain incentives. With the country opening up and the return of work on the ground, the employer’s role in vaccination is becoming increasingly important. A quarter of those who hesitate and have a job said they would get the shot if their employer arranged for a workplace vaccination. Almost as many would agree if their employers gave them financial incentives between $ 50 and $ 200.

Overall, the strong growth in adults who have either received a dose of the vaccine or who are inclined to receive it is most likely due to their increased familiarity with the term. Surveys show that as they get to know more friends and relatives who got the shot, it is easier for them to imagine getting it themselves.